BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND SLC45A3, IPCA-6, 85414, ENSG00000158715, Q96JT2, PRST, PCANAP6, IPCA6
40 results:

  • 1. Prostein expression in human tumors: a tissue microarray study on 19,202 tumors from 152 different Tumor entities.
    Viehweger F; Böcker C; Weidemann S; Freytag M; Menz A; Büscheck F; Luebke AM; Putri D; Kluth M; Hube-Magg C; Hinsch A; Lennartz M; Lutz F; Reiswich V; Höflmayer D; Fraune C; Möller K; Bernreuther C; Lebok P; Sauter G; Steurer S; Dum D; Marx AH; Simon R; Krech T; Clauditz TS; Jacobsen F; Gorbokon N; Burandt E; Minner S; Kind S
    Diagn Pathol; 2024 Jan; 19(1):12. PubMed ID: 38218896
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Transcriptomic profiling and genomic rearrangement landscape of Nigerian prostate cancer.
    Mavura Y; Song H; Xie J; Tamayo P; Mohammed A; Lawal AT; Bello A; Ibrahim S; Faruk M; Huang FW
    Prostate; 2023 Apr; 83(5):395-402. PubMed ID: 36598071
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comprehensive assessment of anaplastic lymphoma kinase in localized and metastatic prostate cancer reveals targetable alterations.
    Patel RA; Coleman I; Roudier MP; Konnick EQ; Hanratty B; Dumpit R; Lucas JM; Ang LS; Low JY; Tretiakova MS; Ha G; Lee JK; True LD; De Marzo AM; Nelson PS; Morrissey C; Pritchard CC; Haffner MC
    Cancer Res Commun; 2022 May; 2(5):277-285. PubMed ID: 36337169
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Characterization of stage-specific tumor progression in TMPRSS2-ERG (fusion)-driven and non-fusion-driven prostate cancer in GEM models.
    Raina K; Kant R; Prasad RR; Kandhari K; Tomar M; Mishra N; Kumar R; Fox JT; Sei S; Shoemaker RH; Chen Y; Maroni P; Agarwal C; Agarwal R
    Mol Carcinog; 2022 Jul; 61(7):717-734. PubMed ID: 35452553
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Mapping genetic variability in mature miRNAs and miRNA binding sites in prostate cancer.
    Lee B; Li JL; Marchica J; Mercola M; Patel V; Perera RJ
    J Hum Genet; 2021 Nov; 66(11):1127-1137. PubMed ID: 34099864
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Fusion transcript detection using spatial transcriptomics.
    Friedrich S; Sonnhammer ELL
    BMC Med Genomics; 2020 Aug; 13(1):110. PubMed ID: 32753032
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Variant analysis of prostate cancer in Japanese patients and a new attempt to predict related biological pathways.
    Kasajima R; Yamaguchi R; Shimizu E; Tamada Y; Niida A; Tremmel G; Kishida T; Aoki I; Imoto S; Miyano S; Uemura H; Miyagi Y
    Oncol Rep; 2020 Mar; 43(3):943-952. PubMed ID: 32020225
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Retention of Interstitial Genes between
    Murphy SJ; Kosari F; Karnes RJ; Nasir A; Johnson SH; Gaitatzes AG; Smadbeck JB; Rangel LJ; Vasmatzis G; Cheville JC
    Cancer Res; 2017 Nov; 77(22):6157-6167. PubMed ID: 29127096
    [No Abstract]    [Full Text] [Related]  

  • 9. slc45a3-ELK4 functions as a long non-coding chimeric RNA.
    Qin F; Zhang Y; Liu J; Li H
    Cancer Lett; 2017 Sep; 404():53-61. PubMed ID: 28716526
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Novel transcription-induced fusion RNAs in prostate cancer.
    Zhao S; Løvf M; Carm KT; Bakken AC; Hoff AM; Skotheim RI
    Oncotarget; 2017 Jul; 8(30):49133-49143. PubMed ID: 28467780
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Identification of a Novel Autoimmune Peptide Epitope of Prostein in prostate cancer.
    Pin E; Henjes F; Hong MG; Wiklund F; Magnusson P; Bjartell A; Uhlén M; Nilsson P; Schwenk JM
    J Proteome Res; 2017 Jan; 16(1):204-216. PubMed ID: 27700103
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Lipocalin 2 over-expression facilitates progress of castration-resistant prostate cancer via improving androgen receptor transcriptional activity.
    Ding G; Wang J; Feng C; Jiang H; Xu J; Ding Q
    Oncotarget; 2016 Sep; 7(39):64309-64317. PubMed ID: 27602760
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Concurrent TMPRSS2-ERG and slc45a3-ERG rearrangements plus PTEN loss are not found in low grade prostate cancer and define an aggressive tumor subset.
    Hernández S; Font-Tello A; Juanpere N; de Muga S; Lorenzo M; Salido M; Fumadó L; Serrano L; Cecchini L; Serrano S; Lloreta J
    Prostate; 2016 Jun; 76(9):854-65. PubMed ID: 26959281
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Role of CTCF in Regulating slc45a3-ELK4 Chimeric RNA.
    Qin F; Song Y; Zhang Y; Facemire L; Frierson H; Li H
    PLoS One; 2016; 11(3):e0150382. PubMed ID: 26938874
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.
    Kim S; Shin C; Jee SH
    Gene; 2015 Feb; 556(2):199-205. PubMed ID: 25434496
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Transcription-mediated chimeric RNAs in prostate cancer: time to revisit old hypothesis?
    Ren G; Zhang Y; Mao X; Liu X; Mercer E; Marzec J; Ding D; Jiao Y; Qiu Q; Sun Y; Zhang B; Yeste-Velasco M; Chelala C; Berney D; Lu YJ
    OMICS; 2014 Oct; 18(10):615-24. PubMed ID: 25188740
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A genome-wide association study of serum levels of prostate-specific antigen in the Japanese population.
    Terao C; Terada N; Matsuo K; Kawaguchi T; Yoshimura K; Hayashi N; Shimizu M; Soga N; Takahashi M; ; Kotoura Y; Yamada R; Ogawa O; Matsuda F
    J Med Genet; 2014 Aug; 51(8):530-6. PubMed ID: 24919509
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A comparative study of ERG status assessment on DNA, mRNA, and protein levels using unique samples from a Swedish biopsy cohort.
    Svensson MA; Perner S; Ohlson AL; Day JR; Groskopf J; Kirsten R; Sollie T; Helenius G; Andersson SO; Demichelis F; Andrén O; Rubin MA
    Appl Immunohistochem Mol Morphol; 2014; 22(2):136-41. PubMed ID: 24517914
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Novel 5' fusion partners of ETV1 and ETV4 in prostate cancer.
    Barros-Silva JD; Paulo P; Bakken AC; Cerveira N; Løvf M; Henrique R; Jerónimo C; Lothe RA; Skotheim RI; Teixeira MR
    Neoplasia; 2013 Jul; 15(7):720-6. PubMed ID: 23814484
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Quantification of protein expression in cells and cellular subcompartments on immunohistochemical sections using a computer supported image analysis system.
    Braun M; Kirsten R; Rupp NJ; Moch H; Fend F; Wernert N; Kristiansen G; Perner S
    Histol Histopathol; 2013 May; 28(5):605-10. PubMed ID: 23361561
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.